{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:02:33Z","timestamp":1755216153089,"version":"3.43.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,3]]},"DOI":"10.7759\/cureus.89301","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T01:13:03Z","timestamp":1754269983000},"source":"Crossref","is-referenced-by-count":0,"title":["Measurement of Amiodarone Levels in the Breast Milk of a Japanese Woman With Peripartum Cardiomyopathy"],"prefix":"10.7759","author":[{"given":"Chiho","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Wachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.18-729","article-title":"Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality","volume":"60","author":"Isogai T","year":"2019","unstructured":"Isogai T, Kamiya CA. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality. Int Heart J. 2019, 60:503-11. 10.1536\/ihj.18-729","journal-title":"Int Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2016.01.005","article-title":"The increase in the rate of maternal deaths related to cardiovascular disease in Japan from 1991-1992 to 2010-2012","volume":"69","author":"Tanaka H","year":"2017","unstructured":"Tanaka H, Katsuragi S, Osato K, et al.. The increase in the rate of maternal deaths related to cardiovascular disease in Japan from 1991-1992 to 2010-2012. J Cardiol. 2017, 69:74-8. 10.1016\/j.jjcc.2016.01.005","journal-title":"J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2204143","article-title":"Amiodarone in ventricular arrhythmias: still a valuable resource?","volume":"22","author":"Pannone L","year":"2021","unstructured":"Pannone L, D'Angelo G, Gulletta S, et al.. Amiodarone in ventricular arrhythmias: still a valuable resource?. Rev Cardiovasc Med. 2021, 22:1383-92. 10.31083\/j.rcm2204143","journal-title":"Rev Cardiovasc Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-1212","article-title":"JCS\/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias","volume":"86","author":"Ono K","year":"2022","unstructured":"Ono K, Iwasaki YK, Akao M, et al.. JCS\/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias. Circ J. 2022, 86:1790-924. 10.1253\/circj.CJ-20-1212","journal-title":"Circ J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(92)90174-w","article-title":"Use of amiodarone during pregnancy","volume":"43","author":"Plomp TA","year":"1992","unstructured":"Plomp TA, Vulsma T, Vijlder JJ. Use of amiodarone during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992, 43:201-7. 10.1016\/0028-2243(92)90174-w","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1093\/ehj\/9.1.106","article-title":"Amiodarone during pregnancy","volume":"9","author":"Strunge P","year":"1988","unstructured":"Strunge P, Frandsen J, Andreasen F. Amiodarone during pregnancy. Eur Heart J. 1988, 9:106-9.","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343825","article-title":"Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment","volume":"24","author":"Bartalena L","year":"2001","unstructured":"Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest. 2001, 24:116-30. 10.1007\/BF03343825","journal-title":"J Endocrinol Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/fn.88.3.f255","article-title":"Amiodarone and breast feeding","volume":"88","author":"Hall CM","year":"2003","unstructured":"Hall CM, McCormick KP. Amiodarone and breast feeding. Arch Dis Child Fetal Neonatal Ed. 2003, 88:F255-4. 10.1136\/fn.88.3.f255","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria S","year":"2005","unstructured":"Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. 2005, 118:706-14. 10.1016\/j.amjmed.2004.11.028","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.272","article-title":"Breast milk concentrations of amiodarone, desethylamiodarone, and bisoprolol following short-term drug exposure: two case reports","volume":"54","author":"Khurana R","year":"2014","unstructured":"Khurana R, Bin Jardan YA, Wilkie J, Brocks DR. Breast milk concentrations of amiodarone, desethylamiodarone, and bisoprolol following short-term drug exposure: two case reports. J Clin Pharmacol. 2014, 54:828-31. 10.1002\/jcph.272","journal-title":"J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12439","article-title":"Intravenous single administration of amiodarone and breastfeeding","volume":"33","author":"Javot L","year":"2019","unstructured":"Javot L, Pape E, Y\u00e9l\u00e9h\u00e9-Okouma M, et al.. Intravenous single administration of amiodarone and breastfeeding. Fundam Clin Pharmacol. 2019, 33:367-72. 10.1111\/fcp.12439","journal-title":"Fundam Clin Pharmacol"},{"key":"ref12","unstructured":"Pharmaceutical interview form, amiodarone (2024) [In Japanese]. (2025). Accessed. June 22. 2025: https:\/\/med.toaeiyo.co.jp\/products\/amiodaroneinj\/pdf\/if-amzi.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.152652","article-title":"Amiodarone: an effective antiarrhythmic drug with unusual side effects","volume":"96","author":"van Erven L","year":"2010","unstructured":"van Erven L, Schalij MJ. Amiodarone: an effective antiarrhythmic drug with unusual side effects. Heart. 2010, 96:1593-600. 10.1136\/hrt.2008.152652","journal-title":"Heart"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000106821","article-title":"Ontogenesis of thyroid function and interactions with maternal function","volume":"10","author":"Obregon MJ","year":"2007","unstructured":"Obregon MJ, Calvo RM, Escobar Del Rey F, Morreale de Escobar G. Ontogenesis of thyroid function and interactions with maternal function. Endocr Dev. 2007, 10:86-98. 10.1159\/000106821","journal-title":"Endocr Dev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1542\/neo.21-1-e30","article-title":"Thyroid function during the fetal and neonatal periods","volume":"21","author":"Eng L","year":"2020","unstructured":"Eng L, Lam L. Thyroid function during the fetal and neonatal periods. Neoreviews. 2020, 21:e30-6. 10.1542\/neo.21-1-e30","journal-title":"Neoreviews"},{"key":"ref16","article-title":"Development of the generic amiodarone injection which can be stored at room temperature for three years","volume":"55","author":"Yamada Y","year":"2018","unstructured":"Yamada Y, Mori K, Yamaguti K. Development of the generic amiodarone injection which can be stored at room temperature for three years. 2018, 55:361-8."},{"key":"ref17","unstructured":"Overview of the 2010 Infant and Toddler Physical Development Survey [In Japanese]. (2025). Accessed. June 22, 2025: https:\/\/www.mhlw.go.jp\/stf\/houdou\/0000042861.html."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1253\/jjcsc.25.1_75","article-title":"Diagnosis and treatment of peripartum","volume":"25","author":"Kamiya C","year":"2017","unstructured":"Kamiya C. Diagnosis and treatment of peripartum. Circ J. 2017, 25:75-81. 10.1253\/jjcsc.25.1_75","journal-title":"Circ J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-22-0827","article-title":"JCS\/JHRS 2022 Guideline on diagnosis and risk assessment of arrhythmia","volume":"88","author":"Takase B","year":"2024","unstructured":"Takase B, Ikeda T, Shimizu W, et al.. JCS\/JHRS 2022 Guideline on diagnosis and risk assessment of arrhythmia. Circ J. 2024, 88:1509-95. 10.1253\/circj.CJ-22-0827","journal-title":"Circ J"},{"key":"ref20","unstructured":"JCS 2018 Guideline on indication and management of pregnancy and delivery in women with heart disease [In Japanese]. (2025). Accessed. June 29, 2025: https:\/\/www.j-circ.or.jp\/cms\/wp-content\/uploads\/2018\/06\/JCS2018_akagi_ikeda.pdf."},{"article-title":"Febuxostat","year":"2025","key":"ref21","unstructured":"Febuxostat. Drugs and Lactation Database (LactMed\u00ae) [Internet]. National Institute of Child Health and Human Development, Bethesda; 2025."},{"article-title":"Pitavastatin","year":"2025","key":"ref22","unstructured":"Pitavastatin. Drugs and Lactation Database (LactMed\u00ae) [Internet]. National Institute of Child Health and Human Development, Bethesda; 2025."},{"key":"ref23","unstructured":"Pharmaceutical Interview Form, Takecab (2024) [In Japanese]. (2025). Accessed. February 24, 2025: https:\/\/pins.japic.or.jp\/pdf\/medical_interview\/IF00006509.pdf."},{"key":"ref24","unstructured":"Pharmaceutical Interview Form, Tanatril. (2025). [In Japanese]. (2025). Accessed. February 24, 2025: https:\/\/pins.japic.or.jp\/pdf\/medical_interview\/IF00000561.pdf."},{"key":"ref25","article-title":"Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 4th communication: placental transfer and secretion into milk in rats","volume":"42","author":"Endo M","year":"1992","unstructured":"Endo M, Yamada Y, Kohno M, Suzuki T, Otsuka M, Takaiti O. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 4th communication: placental transfer and secretion into milk in rats. Arzneimittelforschung. 1992, 42:483-9.","journal-title":"Arzneimittelforschung"},{"key":"ref26","unstructured":"Pharmaceutical Interview Form, Lixiana. (2024). [In Japanese]. (2025). Accessed. February 24, 2025: https:\/\/pins.japic.or.jp\/pdf\/medical_interview\/IF00009303.pdf."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-25-0002","article-title":"JCS\/JHFS 2025 Guideline on diagnosis and treatment of heart failure","volume":"89","author":"Kitai T","year":"2025","unstructured":"Kitai T, Kohsaka S, Kato T, et al.. JCS\/JHFS 2025 Guideline on diagnosis and treatment of heart failure. Circ J. 2025, 89:1278-444. 10.1253\/circj.CJ-25-0002","journal-title":"Circ J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90242-9","article-title":"Human experience with amiodarone in the embryonic period","volume":"73","author":"Ovadia M","year":"1994","unstructured":"Ovadia M, Brito M, Hoyer GL, Marcus FI. Human experience with amiodarone in the embryonic period. Am J Cardiol. 1994, 73:316-7. 10.1016\/0002-9149(94)90242-9","journal-title":"Am J Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)91498-6","article-title":"Pregnancy outcome after gestational exposure to amiodarone in Canada","volume":"172","author":"Magee La","year":"1995","unstructured":"Magee La, Downar E, Sermer M, Boulton BC, Allen LC, Koren G. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol. 1995, 172:1307-11. 10.1016\/0002-9378(95)91498-6","journal-title":"Am J Obstet Gynecol"},{"key":"ref30","article-title":"Guidelines for the Diagnosis and Treatment of Pediatric Arrhythmias [In Japanese]","author":"Naokata S","year":"2025","unstructured":"Naokata S, Mari I, Daichi U. Guidelines for the Diagnosis and Treatment of Pediatric Arrhythmias [In Japanese]. 2025."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa686","article-title":"Evaluation and treatment of amiodarone-induced thyroid disorders","volume":"106","author":"Ylli D","year":"2021","unstructured":"Ylli D, Wartofsky L, Burman KD. Evaluation and treatment of amiodarone-induced thyroid disorders. J Clin Endocrinol Metab. 2021, 106:226-36. 10.1210\/clinem\/dgaa686","journal-title":"J Clin Endocrinol Metab"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.11253\/ninchishinkeikagaku.23.45","article-title":"About the Enjoji method of infant development analysis","volume":"23","author":"Kurokawa T","year":"2021","unstructured":"Kurokawa T. About the Enjoji method of infant development analysis. Hist Pediatr Neurol. 2021, 23:45-51. 10.11253\/ninchishinkeikagaku.23.45","journal-title":"Hist Pediatr Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00201","article-title":"Volume of distribution in drug design","volume":"58","author":"Smith DA","year":"2015","unstructured":"Smith DA, Beaumont K, Maurer TS, Di L. Volume of distribution in drug design. J Med Chem. 2015, 58:5691-8. 10.1021\/acs.jmedchem.5b00201","journal-title":"J Med Chem"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1979.tb11240.x","article-title":"Changes in fat, fat-free mass and body water in human normal pregnancy","volume":"86","author":"Pipe NG","year":"1979","unstructured":"Pipe NG, Smith T, Halliday D, Edmonds CJ, Williams C, Coltart TM. Changes in fat, fat-free mass and body water in human normal pregnancy. Br J Obstet Gynaecol. 1979, 86:929-40. 10.1111\/j.1471-0528.1979.tb11240.x","journal-title":"Br J Obstet Gynaecol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2013.109","article-title":"Perinatal factors relating to changes in maternal body fat in late gestation","volume":"33","author":"Maple-Brown LJ","year":"2013","unstructured":"Maple-Brown LJ, Roman NM, Thomas A, Presley LH, Catalano PM. Perinatal factors relating to changes in maternal body fat in late gestation. J Perinatol. 2013, 33:934-8. 10.1038\/jp.2013.109","journal-title":"J Perinatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.28.1934","article-title":"Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population","volume":"28","author":"Kashima A","year":"2005","unstructured":"Kashima A, Funahashi M, Fukumoto K, Komamura K, Kamakura S, Kitakaze M, Ueno K. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population. Biol Pharm Bull. 2005, 28:1934-8. 10.1248\/bpb.28.1934","journal-title":"Biol Pharm Bull"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/360998-measurement-of-amiodarone-levels-in-the-breast-milk-of-a-japanese-woman-with-peripartum-cardiomyopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T01:13:06Z","timestamp":1754269986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/360998-measurement-of-amiodarone-levels-in-the-breast-milk-of-a-japanese-woman-with-peripartum-cardiomyopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,3]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.89301","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,3]]}}}